<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bioimpacts</journal-id><journal-id journal-id-type="iso-abbrev">Bioimpacts</journal-id><journal-id journal-id-type="publisher-id">BioImpacts</journal-id><journal-title-group><journal-title>BioImpacts : BI</journal-title></journal-title-group><issn pub-type="ppub">2228-5652</issn><issn pub-type="epub">2228-5660</issn><issn-l>2228-5652</issn-l><publisher><publisher-name>Tabriz University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4597161</article-id><article-id pub-id-type="doi">10.15171/bi.2015.17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>In vitro antimalarial activity of different extracts of Eremostachys macrophylla  Montbr. &amp; Auch. </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Asnaashari</surname><given-names>Solmaz</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Heshmati Afshar</surname><given-names>Fariba</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref><xref ref-type="aff" rid="A02">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ebrahimi</surname><given-names>Atefeh</given-names></name><xref ref-type="aff" rid="A03">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bamdad Moghadam</surname><given-names>Sedigheh</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Delazar</surname><given-names>Abbas</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref><xref ref-type="aff" rid="A03">
<sup>3</sup>
</xref><xref rid="COR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A01"><sup>1</sup> Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
</aff><aff id="A02"><sup>2</sup> Faculty of Traditional Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
</aff><aff id="A03"><sup>3</sup> Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
</aff><author-notes><corresp id="COR1"><label>*</label><bold>Corresponding author:</bold> Abbas Delazar, <email>delazara@tbzmed.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>19</day><month>8</month><year>2015</year></pub-date><volume>5</volume><issue>3</issue><fpage>135</fpage><lpage>140</lpage><history><date date-type="received"><day>04</day><month>1</month><year>2015</year></date><date date-type="rev-recd"><day>05</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>19</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>© 2015 The Author(s)</copyright-statement><copyright-year>2015</copyright-year><license><license-p>
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>). Non-commercial uses of the work are permitted, provided the original work is properly cited.
</license-p></license></permissions><self-uri xlink:href="http://bi.tbzmed.ac.ir">http://bi.tbzmed.ac.ir</self-uri><abstract><p content-type="toc-graphic"><SecTag type="ABS"><text><SENT sid="1" pm="."><plain> </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Introduction:The risk of drug resistance and the use of medicinal plants in malaria prevention and treatment have led to the search for new antimalarial compounds with natural origin. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="3" pm="."><plain>Methods:In the current study, six extracts with different polarity from aerial parts and rhizomes of Eremostachys macrophylla Montbr. &amp; Auch., were screened for their antimalarial properties by cell-free β-hematin formation assay. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="4" pm="."><plain>Results: Dichloromethane (DCM) extracts of both parts of plant showed significant antimalarial activities with IC50 values of 0.797 ± 0.016 mg/mL in aerial parts and 0.324 ± 0.039 mg/mL in rhizomes compared to positive control (Chloroquine, IC50 = 0.014 ± 0.003 mg/mL, IC90 = 0.163 ± 0.004 mg/mL). </plain></SENT>
<SENT sid="5" pm="."><plain>Bioactivity-guided fractionation of the most potent part (DCM extract of rhizomes) by vacuum liquid chromatography (VLC) afforded seven fractions. </plain></SENT>
<SENT sid="6" pm="."><plain>Sixty percent ethyl acetate/n-hexane fraction showed considerable antimalarial activity with IC50 value of 0.047 ± 0.0003 mg/mL. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>Conclusion: From 6 extracts with different polarity of E. macrophylla,s aerial parts and rhizomes, the DCM extract of both parts were the most active extract in this assay. </plain></SENT>
<SENT sid="8" pm="."><plain>The preliminary phytochemical study on the VLC fractions of the most potent part persuades us to focus on purifying the active components of these extracts and to conduct further investigation towards in vivo evaluation. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd><italic>Eremostachys macrophylla</italic></kwd><kwd>Antimalaria</kwd><kwd>Cell free assay</kwd><kwd>GC-MS</kwd></kwd-group></SecTag><counts><fig-count count="2"/><table-count count="2"/><ref-count count="53"/><page-count count="6"/></counts></article-meta></front><body><SecTag type="INTRO"><sec sec-type="introduction" id="s1"><title><text><SENT sid="9" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="10" pm="."><plain>Malaria as one of the oldest recorded diseases is considered as the major parasitic disease in tropical and subtropical areas of the world, imposing significant morbidity and often mortality where they occur.1,2 Each year more than 216 million new cases and approximately 655000 deaths of malaria are diagnosed and recorded, most of which are children.3,4 This global ailment is caused by Plasmodium species, of which P. falciparum is the most deadly pathogen, and is accountable for over 85% of cases.5,6 In Iran, malaria is one of the most crucial parasitic diseases in the south-eastern areas, responsible for around 95% of all malaria cases in the country.3 </plain></SENT>
</text></p><p><text><SENT sid="11" pm="."><plain>Chloroquine was synthesized for the first time in 1934 and designated as the chosen drug for treatment of malaria in 1946. </plain></SENT>
<SENT sid="12" pm="."><plain>It is known as the cheapest and commonly used drug for the treatment of malaria.5,7,8 Chloroquine is thought to display its antimalarial activity by inhibiting the crystallization of toxic heme produced during proteolysis of hemoglobin in the parasite vacuoles.9 Unfortunately, this medication has become ineffective due to the generation of chloroquine-resistant species of the malaria parasite.5,7,8 </plain></SENT>
</text></p><p><text><SENT sid="13" pm="."><plain>Nowadays, medicinal plants, as a new resource, are popular and utilized in the prevention and treatment of malaria in different parts of the world.6-8,10,11 For instance, artemisinin as a natural product from an indigenous herb in China, was derived from the plant Artemisia annua in 1972. </plain></SENT>
<SENT sid="14" pm="."><plain>It has been growing attention to this plant since the isolation of artemisinin because of its distinguished clinical effects as a potent antimalarial agent.7,12-14 Artemisinin with an endoperoxide sesquiterpene lactone structure can abolish parasite of all stages by a reductive interaction with free heme, resulting in generation of some types of free radicals that could alkylate parasite proteins and damage membranes. </plain></SENT>
<SENT sid="15" pm="."><plain>Artemisinin also acts by blocking free heme biocrystallization (like 4-aminoquinolines) and hemoglobin degradation.14 World Health Organization (WHO) recommended artemisinin-based combination therapy (ACT) as the first-line treatment of unsophisticated malaria in April 2002.15 In the last few years, WHO has recommended withdrawal of the oral artemisinin-based monotherapies from the market due to the risk of emergence of artemisinin-resistant parasites;14,16 therefore, several new researches have been conducted to find new natural sources of antimalarial drugs.17-21 Based on these investigations, remarkable diversity of new natural products such as coumarin derivatives,22,23 flavonoides,24,25 stilbenes,26-28 sesquiterpenes,29,30 diterpenes,31,32 steroids,33 alkaloids,34-37 etc. showed antiplasmodial activities in different in vitro assays. </plain></SENT>
</text></p><p><text><SENT sid="16" pm="."><plain>In the current study, for the first time, different extracts of E. macrophylla were evaluated from antimalarial effects viewpoints. E. macrophylla (family: Lamiaceae alt. </plain></SENT>
<SENT sid="17" pm="."><plain>Labiatae; subfamily: Lamioideae) is one of the 15 endemic Iranian species of the Eremostachys genus. </plain></SENT>
<SENT sid="18" pm="."><plain>It is a perennial plant with bulky rhizomes.38 According to previous studies containing traditional knowledge and clinical findings, a number of Eremostachys species are applied as local analgesic and anti-inflammatory agents. </plain></SENT>
<SENT sid="19" pm="."><plain>Also this genus has shown antinociceptive, antidepressant and antibacterial activities.39-44 The main objectives of this study were to investigate on (a) the antimalarial activity of different extracts of aerial parts and rhizomes of this plant, (b) fractionation of the most potent extract, (c) determination of the most potent fractions, and (d) identification of the chemical composition of them by GC-MS. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="s2"><title><text><SENT sid="20" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec id="s2-1"><title><text><SENT sid="21" pm="."><plain>Chemicals </plain></SENT>
</text></title><p><text><SENT sid="22" pm="."><plain>All the solvents used for extraction and fractionation were purchased from Caledon Labs (Halton Hills, Ontario, Canada). </plain></SENT>
<SENT sid="23" pm="."><plain>Hematin porcine, chloroquine diphosphate, sodium dodecyl sulfate (SDS), sodium acetate, magnesium sulfate, sodium hydrogen phosphate, sodium chloride, potassium chloride, sodium hydroxide, glucose, and sodium bicarbonate were purchased from Sigma-Aldrich Company Ltd (Dorset, United kingdom). </plain></SENT>
<SENT sid="24" pm="."><plain>Oleic acid was obtained from Fluka (Gujarat, India) and dimethylsulfoxide, hydrochloric acid, and silica gel 60 (0.040–0.063 mm) from Merck company (Darmstadt, Germany). </plain></SENT>
</text></p></sec><sec id="s2-2"><title><text><SENT sid="25" pm="."><plain>Plant material </plain></SENT>
</text></title><p><text><SENT sid="26" pm="."><plain>The aerial parts and rhizomes of E. macrophylla Montbr. &amp; Auch. were collected respectively during July and September–October 2012 from Sahand mountains in East Azarbaijan province in Iran [37.759 (37° 45' 32.4" N) latitude 45.9783 (45° 58' 41.9" E) longitude and altitude 1950 m above sea level]. </plain></SENT>
<SENT sid="27" pm="."><plain>A voucher specimen (Tbz-FPh.739) has been deposited in the herbarium of the Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. </plain></SENT>
</text></p></sec><sec id="s2-3"><title><text><SENT sid="28" pm="."><plain>Extraction </plain></SENT>
</text></title><p><text><SENT sid="29" pm="."><plain>Air-dried and ground aerial parts and rhizomes of E. macrophylla (100 g each) were Soxhlet extracted respectively with n-Hexane, DCM, and methanol (MeOH) (1 L each). </plain></SENT>
<SENT sid="30" pm="."><plain>All obtained extracts were separately concentrated using a rotary evaporator at a maximum temperature of 45°C. </plain></SENT>
</text></p></sec><sec id="s2-4"><title><text><SENT sid="31" pm="."><plain>Fractionation </plain></SENT>
</text></title><p><text><SENT sid="32" pm="."><plain>An amount of 1.1 g of DCM extract from rhizomes of E. macrophylla was fractionated by vacuum liquid chromatography (VLC) over silica gel (20 g) with solvent mixtures of increasing polarities: ethyl acetate/n-hexane (i.e., at ratios of 10:90; 20:80; 40:60; 60:40; 80:20; 100:0) and methanol. </plain></SENT>
<SENT sid="33" pm="."><plain>All the fractions were fully dried using a rotary evaporator at a maximum temperature of 45°C. </plain></SENT>
</text></p></sec><sec id="s2-5"><title><text><SENT sid="34" pm="."><plain>Antimalarial cell free assay </plain></SENT>
</text></title><p><text><SENT sid="35" pm="."><plain>Antimalarial activity of plant extracts was evaluated by the method explained by Afshar et al45 with some modifications. </plain></SENT>
<SENT sid="36" pm="."><plain>Briefly, varying concentrations (0–2 mg/mL in DMSO) of the extracts and fractions were produced. </plain></SENT>
<SENT sid="37" pm="."><plain>The reaction mixtures were incubated with 3 mM of hematin, 10.0 mM oleic acid, and 1 M HCl. </plain></SENT>
<SENT sid="38" pm="."><plain>The final volume was adjusted to 1.0 mL volume using sodium acetate buffer, pH 5, overnight at 37°C with constant gentle shaking. </plain></SENT>
<SENT sid="39" pm="."><plain>Chloroquine diphosphate was used as a positive control. </plain></SENT>
<SENT sid="40" pm="."><plain>After incubation, samples were centrifuged (14000 rpm, 10 min, at 21°C) and the hemozoin pellet was repeatedly washed with incubation (15 min at 37°C with regular shaking) in 2.5% (w/v) SDS in phosphate buffered saline followed by a final wash in 0.1 M sodium bicarbonate until the supernatant was clear (usually 3–8 washes). </plain></SENT>
<SENT sid="41" pm="."><plain>After the final wash, the supernatant was discarded and the pellets were dissolved in 1.0 mL of 0.1 M NaOH before determining the hemozoin content by measuring the absorbance at 400 nm (Spectronic Genesys spectrophotometer). </plain></SENT>
<SENT sid="42" pm="."><plain>The results were recorded as % inhibition (I%) of heme crystallization compared to negative control (DMSO) using the following equation: </plain></SENT>
</text></p><p><text><SENT sid="43" pm="."><plain>I% = [(AN−AS)/AN]×100, where, AN is absorbance of negative control and AS is absorbance of test samples. </plain></SENT>
</text></p></sec><sec id="s2-6"><title><text><SENT sid="44" pm="."><plain>GC-MS analysis of potent fractions </plain></SENT>
</text></title><p><text><SENT sid="45" pm="."><plain>GC–MS analyses were carried out on a Shimadzu QP-5050A GC–MS system (Shimadzu Corp., Kyoto, Japan) equipped with a DB-1 fused silica column (60 m × 0.25 mm i.d., film thickness 0.25 µm); oven temperature, rising from 100°C to 310°C at a rate of 5°C; injector temperature, 280°C; carrier gas, helium at a flow rate of 1.0 mL/min; split ratio, 1:19; ionization energy, 70 eV; scan time, 1 s; mass range, 30–600 amu. </plain></SENT>
</text></p></sec><sec id="s2-7"><title><text><SENT sid="46" pm="."><plain>Identification of components </plain></SENT>
</text></title><p><text><SENT sid="47" pm="."><plain>Identification of the components was based on direct comparison of the retention times and mass spectral data with those for standard compounds, and computer matching with the NIST 21, NIST 107, and WILEY229 library, as well as by comparison of the fragmentation patterns of the mass spectra with those reported in the literature (Adams 2004). </plain></SENT>
</text></p></sec><sec id="s2-8"><title><text><SENT sid="48" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="49" pm="."><plain>All experiments were performed in triplicate and presented as the Mean ± SD. </plain></SENT>
<SENT sid="50" pm="."><plain>Data were analyzed by Microsoft Excel 2010. </plain></SENT>
<SENT sid="51" pm="."><plain>The IC50 and IC90 values were calculated by nonlinear regression analysis. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="s3"><title><text><SENT sid="52" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="53" pm="."><plain>The results from the cell free β-hematin formation assay of six different extracts from aerial parts and rhizomes of E. macrophylla and seven fractions of the most potent extract as well as the extraction and fractionation yields are listed in Table 1. </plain></SENT>
<SENT sid="54" pm="."><plain>The inhibition of β-hematin formation represented as percentage (I %) and standard deviations (n = 3) are considered for each extract/fraction. </plain></SENT>
<SENT sid="55" pm="."><plain>The values of IC50 and IC90 were measured graphically by plotting concentrations versus percentage of inhibition. </plain></SENT>
<SENT sid="56" pm="."><plain>Chloroquine was used as positive control with the most potent antimalarial activity and the extracts solvent (DMSO) was used as negative control without any antimalarial activity. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" orientation="portrait" position="float"><label>
Table 1
</label><caption><title><text><SENT sid="57" pm="."><plain>The 50% and 90% inhibition concentrations (mg/mL) of active extracts and VLC fractions of DCM extract of E. macrophylla rhizomes in β-hematin formation assay </plain></SENT>
</text></title></caption><table frame="hsides" rules="none"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none;background-color:#def0fa"><td rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>Extracts/fractions </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>Yields (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>IC50  (mg/mL) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>IC90  (mg/mL) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>DCM (Rhizomes) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain>0.32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>0.324 ± 0.039 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>0.753 ± 0.009 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>DCM (Aerial parts) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>0.43 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>0.797 ± 0.017 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="69" pm="."><plain>0.863 ± 0.018 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="70" pm="."><plain>Fr.10% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>0.591 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>1.319 ± 0.196 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>4.163 ± 0.585 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>Fr. </plain></SENT>
<SENT sid="75" pm="."><plain>20% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>Trace </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>* </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>Fr.40% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>0.55 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>* </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>Fr.60% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>1.91 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>0.047 ± 0.0003 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>0.249 ± 0.023 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>Fr.80% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>7.67 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>0.228 ± 0.002 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>0.379 ±0.021 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>Fr.100% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>9.42 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>0.217 ± 0.001 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>0.432 ± 0.022 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>Fr.MeOH </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>68.18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>0.576 ± 0.011 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>0.857 ± 0.052 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>Chloroquine </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>Positive control </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>0.014 ± 0.003 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>0.163 ± 0.004 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="103" pm="."><plain>Experiment was performed in triplicate and expressed as Mean ± SD. </plain></SENT>
</text></p><p><text><SENT sid="104" pm="."><plain>* No effect. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="105" pm="."><plain>As shown in Table 1, n-Hexane and methanol extracts of aerial parts and rhizomes had no antimalarial activity at all while the DCM extracts of both parts especially DCM extract of rhizomes showed the most potent antimalarial activity compared to the standard antimalarial compound, chloroquine (IC50 = 0.014 ± 0.003 mg/mL, IC90 = 0.163 ± 0.004 mg/mL). </plain></SENT>
<SENT sid="106" pm="."><plain>IC50 values of DCM extract of aerial parts and rhizomes were 0.797 ± 0.016 and 0.324 ± 0.039 mg/mL, respectively. </plain></SENT>
<SENT sid="107" pm="."><plain>This was 0.863 ± 0.018 and 0.753 ± 0.009 mg/mL for IC90 values of this extract, respectively. </plain></SENT>
</text></p><p><text><SENT sid="108" pm="."><plain>As shown in Table 1 and Fig. 1, after fractionation of the most potent extract (DCM extract of rhizomes) by VLC method, the results showed that among the seven different polarity fractions, 60% ethyl acetate/n-hexane fraction had considerable antimalarial activity with IC50 value of 0.047 ± 0.0003 and IC90 value of 0.249 ± 0.023 mg/mL. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F1" orientation="portrait" position="float"><label>
Fig. 1
</label><graphic xlink:href="BI-5-135-g001"/><statement><p><text><SENT sid="109" pm="."><plain>Comparison of IC50 and IC90 values (mg/mL) of active extracts of E. macrophylla, fractions of the most potent extract and chloroquine solution in β-hematin formation assay. </plain></SENT>
<SENT sid="110" pm="."><plain>The values were reported as Mean± SD. </plain></SENT>
</text></p></statement></fig></SecTag><p><text><SENT sid="111" pm="."><plain>Polar fractions of VLC (80% ethyl acetate/n-hexane, 100% ethyl acetate and MeOH fractions) demonstrated remarkable antimalarial effects with close IC50 and IC90 values (Table 1). </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="s4"><title><text><SENT sid="112" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="113" pm="."><plain>Malaria is a life-threatening disease caused by the Anopheles mosquitoes that infects the human body by intracellular parasite of the genus Plasmodium.46 Plasmodium falciparum utilizes host hemoglobin as a main nutrient source for its growth and reproduction. </plain></SENT>
<SENT sid="114" pm="."><plain>This parasite ingests more than 75% of the host hemoglobin during intra-erythrocytic cycle; therefore, substantial amounts of heme is generated as a toxic by-product from massive degradation of hemoglobin.47,48 Subsequently, parasite for protecting itself from the self-produced toxic material has evolved a process through the crystallization of heme into an insoluble, nontoxic crystalline pigment known as hemozoin.14,49,50 Hemozoin is equivalent to β-hematin, which consists of cyclic heme dimers arranged in an ordered crystalline structure through intermolecular hydrogen bonding. </plain></SENT>
<SENT sid="115" pm="."><plain>It is believed to be the most validated target of detoxification. </plain></SENT>
<SENT sid="116" pm="."><plain>Therefore, the inhibition of hemozoin formation is a way for drug screening programs. </plain></SENT>
<SENT sid="117" pm="."><plain>Many different quantitative in vitro methods based on spectral characteristics and differential solubility of monomeric heme and β-hematin has been used for evaluation of antimalarial activities.48,51-53 In this study, 6 extracts and 7 fractions of aerial parts and rhizomes of E. macrophylla were evaluated for their antimalarial activity by an in vitro method. </plain></SENT>
<SENT sid="118" pm="."><plain>Our findings revealed that the n-hexane and the MeOH extracts of both parts of E. macrophylla did not show any significant antimalarial activities but the DCM extracts of both aerial parts and rhizomes showed significant potential antimalarial effects in comparison with negative control. </plain></SENT>
<SENT sid="119" pm="."><plain>It was indicated that potent antimalarial constituents of active extracts might possess medium polarity. </plain></SENT>
<SENT sid="120" pm="."><plain>Among two DCM extracts of E. macrophylla, DCM extract of rhizomes demonstrated the most potent activity (IC50 =0.324 ± 0.039 mg/mL , IC90 = 0.753 ± 0.009mg/mL) which guided to fractionate it by VLC over silica gel with solvent mixtures of increasing polarities (Fig. 2). </plain></SENT>
<SENT sid="121" pm="."><plain>Based upon the results presented in Table 1 and Fig. 1, among the seven fractions obtained by VLC, the 60% ethyl acetate/n-hexane fraction was the most potent fraction with IC50 value of 0.047 ± 0.0003 and IC90 value of 0.249 ± 0.023 mg/mL. </plain></SENT>
<SENT sid="122" pm="."><plain>Other polar fractions, 80% ethyl acetate/n-hexane, 100% ethyl acetate/n-hexane and 100% MeOH, also were determined as significantly potent antimalarial fractions. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F2" orientation="portrait" position="float"><label>
Fig. 2
</label><graphic xlink:href="BI-5-135-g002"/><statement><p><text><SENT sid="123" pm="."><plain>Comparison of % inhibition of heme crystallization between active extracts and fractions of the most potent extract from E. macrophylla, and chloroquine solution in β-hematin formation assay. </plain></SENT>
<SENT sid="124" pm="."><plain>The values were reported as Mean ± SD. </plain></SENT>
</text></p></statement></fig></SecTag><p><text><SENT sid="125" pm="."><plain>GC-MS analysis of fractions with antimalarial activity indicated the presence of steroids, polycyclic aromatic hydrocarbon, diterpenoid derivatives, linear alcohols and fatty acids as major constituents. </plain></SENT>
<SENT sid="126" pm="."><plain>Previous investigations showed that terpenes, steroids, coumarins, flavonoids, phenolic acids, stilbenes, lignans and alkaloids exhibited antiplasmodial activity in different antimalarial assays.22-37 </plain></SENT>
</text></p><p><text><SENT sid="127" pm="."><plain>Based on the results shown in Table 2, in 60% ethyl acetate/n-hexane fraction, steroidal structures were identified as the major active constituents (about 82%).Therefore, it seems that the strong antimalarial activity of this fraction might be related to the presence of steroids derivatives. </plain></SENT>
<SENT sid="128" pm="."><plain>In the case of 80% ethyl acetate/n-hexane and 100% ethyl acetate fractions, fatty acid, polycyclic aromatic hydrocarbon, steroids and their derivatives were identified by GC-MS analysis. </plain></SENT>
<SENT sid="129" pm="."><plain>Additionally, in 100% MeOH fraction, the presence of fatty acids, steroids and diterpenoid derivatives were determined. </plain></SENT>
<SENT sid="130" pm="."><plain>Moreover, based on previous researches, the presence of lipids and other fatty acids in the mixture of active extracts and fractions showed synergistic effects with oleic acid in assay; therefore, the recorded absorbances were higher than the negative control. </plain></SENT>
<SENT sid="131" pm="."><plain>It was exhibited that the values of IC50 and IC90 could be reduced by entirely eliminating the fatty acids and purifying the active antimalarial constituents.14,45 The percentage of fatty acids and their derivatives in 100% MeOH fraction (23.14%) was higher than that in 80% ethyl acetate/n-hexane (5.60%) and 100% ethyl acetate (3.46%) fractions; so the IC50 and IC90 values of 100% MeOH fraction can be extremely reduced by completely removing of fatty acid derivatives. </plain></SENT>
<SENT sid="132" pm="."><plain>In consideration of high yields of 100% MeOH fraction (68.18% of DCM extract) as compared to other active fractions (Table 1), more purification of this fraction would be valuable. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T2" orientation="portrait" position="float"><label>
Table 2
</label><caption><title><text><SENT sid="133" pm="."><plain>Chemical composition of VLC fractions of DCM extract from rhizomes </plain></SENT>
</text></title></caption><table frame="hsides" rules="none"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none;background-color:#def0fa"><td rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>Fraction </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>Total identified content (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>Compounds (content %) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>Fr.10% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>92.47 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>Linear Aldehyde(10.33%), Alkanes (48.30%), fatty acids and their derivatives(12.13%) , steroids and their derivatives(21.70%) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>Fr.20% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>* </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>Fr.40% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>* </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>* </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>Fr.60% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>82.32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>Steroids (Campesterol (9.03%), Ergosta-5, 22-dien-3-ol, 24-methyl-, (3.beta. </plain></SENT>
<SENT sid="149" pm="."><plain>22E)-(6.80%), Clionasterol (66.49%) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>Fr.80% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>84.39 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>Fatty acids and their derivatives (5.60%), steroids and their derivatives (25.04%), Linear Alcohol (8.04%), polycyclic aromatic hydrocarbons (45.71%), </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>Fr.100% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>83.6 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>Fatty acids and their derivatives (3.46%), polycyclic aromatic hydrocarbon (59.46%), steroids and their derivatives (20.68%) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>Fr.100%MeOH </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>97.07 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Fatty acids and their derivatives (23.14%), steroids and their derivatives (54.05%), Diterpenoid derivatives (19.88%) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="159" pm="."><plain>*Not identified. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="160" pm="."><plain>Taken all, based on the GC-MS analysis of VLC fractions and previous studies, it seems that steroid derivatives and diterpenes are as the major active antimalarial constituents in DCM extract of rhizomes. </plain></SENT>
<SENT sid="161" pm="."><plain>Among the seven different polarity fractions, 20% ethyl acetate/n-hexane and 40% ethyl acetate/n-hexane fractions revealed no activity in this assay system, while the last four polar fractions showed the potent activity with close IC50 and IC90 values (Table 1 and Fig. 1). </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec sec-type="conclusion" id="s5"><title><text><SENT sid="162" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><text><SENT sid="163" pm="."><plain>From 6 extracts with different polarity of E. macrophylla,s aerial parts and rhizomes, the DCM extract of both parts were the most active extract in the cell free β-hematin formation assay. </plain></SENT>
<SENT sid="164" pm="."><plain>The preliminary phytochemical study on the VLC fractions of the most potent part (DCM extract of rhizomes) produced compelling results that led us to focus on purifying the active components of these extracts and investigating further on animal models for in vivo evaluation. </plain></SENT>
</text></p></sec></SecTag><sec id="s6"><title><text><SENT sid="165" pm="."><plain>Ethical issues </plain></SENT>
</text></title><p><text><SENT sid="166" pm="."><plain>Not applicable in this study. </plain></SENT>
</text></p></sec><SecTag type="COMP_INT"><sec id="s7"><title><text><SENT sid="167" pm="."><plain>Competing interests </plain></SENT>
</text></title><p><text><SENT sid="168" pm="."><plain>Authors declare no competing interests. </plain></SENT>
</text></p></sec></SecTag><sec id="s8"><title><text><SENT sid="169" pm="."><plain>Research Highlights </plain></SENT>
</text></title><p><text><SENT sid="170" pm="."><plain> What is current knowledge?  √ Plant kingdoms can be potentially rich source of novel antimalarial agents.  √ Resistance to current antimalarial drugs like artemisinin and aminoquinolines has threatened malaria eradication efforts; therefore, several screening programs have been carried out to find new natural sources of antimalarial agents from different plant families.  What is new here?  √ DCM extract from rhizomes of E. macrophylla showed antimalarial activity in in vitro β-hematin formation assay.  √ Fractionation of DCM extract and evaluation of them by GC-MS suggested that steroidal compounds may be responsible for antimalarial activity.   </plain></SENT>
</text></p></sec></body><back><SecTag type="REF"><ref-list><title>References</title><ref id="R1"><text><SENT sid="171" pm="."><plain>1RamazaniAZakeriSSardariSKhodakarimNDinparas DjadidtNIn vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattenseMalar J20101241810.1186/1475-2875-9-124 </plain></SENT>
</text></ref><ref id="R2"><text><SENT sid="172" pm="."><plain>2SoonSLHye-SookKDong-UngLIn vitro antimalarial activity of flavonoids and chalconesBull Korean Chem Soc20072824957 </plain></SENT>
</text></ref><ref id="R3"><text><SENT sid="173" pm="."><plain>3RanjbarMGorgijKMohammadiMHaghdoostAAAnsari-MoghaddamANikpourFEfficacy of applying self-assessment of larviciding operation, Chabahar, IranMalar J20121110.1186/1475-2875-11-32922230255 </plain></SENT>
</text></ref><ref id="R4"><text><SENT sid="174" pm="."><plain>4 World Malaria Report 2012 Fact Sheet; 17 December 2012; http://www.who.int/malaria.  </plain></SENT>
</text></ref><ref id="R5"><text><SENT sid="175" pm="."><plain>5SharmaUSrivastavaKPuriSKSinghCAmino steroids as antimalarial agentsMed Chem Res20081732633410.1007/s00044-007-9068-x </plain></SENT>
</text></ref><ref id="R6"><text><SENT sid="176" pm="."><plain>6SaotoingPVroumsiaTTchobsalaTchuenguem FohouoFNNjan NlogaAMMessiJMedicinal plants used in traditional treatment of malaria in CameroonJ Ecol Nat Environ20113104117 </plain></SENT>
</text></ref><ref id="R7"><text><SENT sid="177" pm="."><plain>7ToluOOOdunayoRAkinsulire IbukunEAPeterOFMedicinal plants useful for malaria therapy in Okeigibo, Ondo State, southwest NigeriaAfr J Trad CAM200741918 </plain></SENT>
</text></ref><ref id="R8"><text><SENT sid="178" pm="."><plain>8CooperRGMagwereTChloroquine: Novel uses &amp; manifestationsIndian J Med Res20081273051618577785 </plain></SENT>
</text></ref><ref id="R9"><text><SENT sid="179" pm="."><plain>9SullivanDJIlyaJRGluzmanYRussellDGGoldbergDEOn the molecular mechanism of chloroquine’s antimalarial actionProc Natl Acad Sci19969311865708876229 </plain></SENT>
</text></ref><ref id="R10"><text><SENT sid="180" pm="."><plain>10RandrianarivelojosiaMRasidimananaVTRabarisonHCheplogoiPKRatsimbasonMMulhollandDAPlants traditionally prescribed to treat Tazo (Malaria) In the easternregion of MadagascarMalar J200321910.1186/1475-2875-2-2512605724 </plain></SENT>
</text></ref><ref id="R11"><text><SENT sid="181" pm="."><plain>11EneACAtawodiSEAmehDAKwanashieHOAgomoPULocally used plants for malaria therapy amongst the Hausa, Yoruba, and Ibo communities in Maiduguri, Northeastern NigeriaIndian J Trad Know2010948690 </plain></SENT>
</text></ref><ref id="R12"><text><SENT sid="182" pm="."><plain>12MuellerMSKarhagombaIBHirtHMWemakorEThe potential of Artemisia annua L as a locally produced remedy for malaria in the tropics: agricultural, chemical and clinical aspectsJ Ethnopharmacol20007348749311091003 </plain></SENT>
</text></ref><ref id="R13"><text><SENT sid="183" pm="."><plain>13PetersWRobinsonBLRossierJCJeffordCWThe Chemotherapy of rodent malaria XLVIII the activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites part 1: studies leading to the development of novel cis-fused cyclopenteno derivativesAnn Trop Med Parasitol199387 </plain></SENT>
</text></ref><ref id="R14"><text><SENT sid="184" pm="."><plain>14MojarrabMShiravandADelazarAHeshmati AfsharFEvaluation of in vitro antimalarial activity of different extracts of Artemisia aucheri Boiss and A armeniaca L and fractions of the most potent extractsScientific World J20141610.1155/2014/825370 </plain></SENT>
</text></ref><ref id="R15"><text><SENT sid="185" pm="."><plain>15ShrettaRYadavPStabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-upMalar J20121111010.1186/1475-2875-11-39922212246 </plain></SENT>
</text></ref><ref id="R16"><text><SENT sid="186" pm="."><plain>16 WHO. </plain></SENT>
<SENT sid="187" pm="."><plain>WHO global malaria program: Malaria report 2013.  </plain></SENT>
</text></ref><ref id="R17"><text><SENT sid="188" pm="."><plain>17CamargoLMde OliveiraSBasanoSGarciaCRAntimalarials and the fight against malaria in BrazilTher Clin Risk Manag2009531131719753125 </plain></SENT>
</text></ref><ref id="R18"><text><SENT sid="189" pm="."><plain>18FattorussoETaglialatela-ScafatiOMarine AntimalarialsMar Drugs2009713015210.3390/md702013019597577 </plain></SENT>
</text></ref><ref id="R19"><text><SENT sid="190" pm="."><plain>19BeroJFrederichMQuetin-LeclercqJAntimalarial compounds isolated from plants used in traditional medicineJ Pharm Pharmacol2009611401143310.1211/jpp/61.11.000119903367 </plain></SENT>
</text></ref><ref id="R20"><text><SENT sid="191" pm="."><plain>20MagadulaJJErastoPBioactive natural products derived from the East African floraNat Prod Rep2009261535155410.1039/b906089h19936385 </plain></SENT>
</text></ref><ref id="R21"><text><SENT sid="192" pm="."><plain>21BatistaRJuniorAJSOliveiraABPlant-derived antimalarial agents: new leads and efficient phytomedicines Part II Non- alkaloidal natural productsMolecules2009143037307210.3390/molecules1408303719701144 </plain></SENT>
</text></ref><ref id="R22"><text><SENT sid="193" pm="."><plain>22RossSAKrishnavenKRadwanMMTakamatsuSBurandtCLConstituents of Zanthoxylum flavum and their antioxidant and antimalarial activitiesNat Prod Commun20083791794 </plain></SENT>
</text></ref><ref id="R23"><text><SENT sid="194" pm="."><plain>23MaCZhangHJTanGTHungNVCuongNMSoejartoDDAntimalarial compounds from Grewia bilamellataJ Nat Prod20066934635010.1021/np050313d16562832 </plain></SENT>
</text></ref><ref id="R24"><text><SENT sid="195" pm="."><plain>24RamanandraibeVGrellierPMartinMTDevilleARamanitrahasimbolaDMourayEAntiplasmodial phenolic compounds from Piptadenia pervilleiPlanta Med20087441742110.1055/s-2008-103432818484535 </plain></SENT>
</text></ref><ref id="R25"><text><SENT sid="196" pm="."><plain>25KhaomekPIchinoCIshiyamaASekiguchiHNamatameMRuangrungsiNIn vitro antimalarial activity of prenylated flavonoids from Erythrina fuscaJ Nat Med20086221722010.1007/s11418-007-0214-z18404327 </plain></SENT>
</text></ref><ref id="R26"><text><SENT sid="197" pm="."><plain>26SonIHChungIMLeeSJMoonHIAntiplasmodial activity of novel stilbene derivatives isolated from Parthenocissus tricuspidata from South KoreaParasitol Res200710123724110.1007/s00436-006-0454-y17211658 </plain></SENT>
</text></ref><ref id="R27"><text><SENT sid="198" pm="."><plain>27ParkWHLeeSJMoonHIAntimalarial activity of a new stilbene glycoside from Parthenocissus tricuspidata in miceAntimicrob Agents Chemother2008523451310.1128/AAC.00562-0818625780 </plain></SENT>
</text></ref><ref id="R28"><text><SENT sid="199" pm="."><plain>28LeeSIYangHDSonIHMoonHIAntimalarial activity of a stilbene glycoside from Pleuropterus ciliinervisAnn Trop Med Parasitol200810218118410.1179/136485908X25235918318941 </plain></SENT>
</text></ref><ref id="R29"><text><SENT sid="200" pm="."><plain>29RukungaGMMuregiFWOmarSAGathirwaJWMuthauraCNPeterMGAnti-plasmodial activity of the extracts and two sesquiterpenes from Cyperus articulatusFitoterapia20087918819010.1016/j.fitote.2007.11.01018234452 </plain></SENT>
</text></ref><ref id="R30"><text><SENT sid="201" pm="."><plain>30PillayPVleggaarRMaharajVJSmithPJLateganCAIsolation and identification of antiplasmodial sesquiterpene lactones from Oncosiphon piluliferumJ Ethnopharmacol2007112717610.1016/j.jep.2007.02.00217350777 </plain></SENT>
</text></ref><ref id="R31"><text><SENT sid="202" pm="."><plain>31JullianVBonduelleCValentinAAcebeyLDuigouAGPrevostMFNew clerodane diterpenoids from Laetia procera (Poepp) Eichler (Flacourtiaceae), with antiplasmodial and antileishmanial activitiesBioorg Med Chem Lett2005155065507010.1016/j.bmcl.2005.07.09016168652 </plain></SENT>
</text></ref><ref id="R32"><text><SENT sid="203" pm="."><plain>32KalauniSKAsihPBSAwaleSSyafruddinDTezukaYBanskotaAHAntimalarial activity of cassane- and norcassane-type diterpenes from Caesalpinia crista and their structure–activity relationshipBiol Pharm Bull2006291050105216651745 </plain></SENT>
</text></ref><ref id="R33"><text><SENT sid="204" pm="."><plain>33AkamTMTanePWaboHKYongJNFanso- FreeSNYConnollyJDA pregnane derivative and an anti-plasmodial labdane diterpenoid from the stem bark of Turraenthus africanusNat Prod Commun20061449452 </plain></SENT>
</text></ref><ref id="R34"><text><SENT sid="205" pm="."><plain>34ToriizukaYKinoshitaEKogureNKitajimaMIshiyamaAOtoguroKNew lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivativesBioorg Med Chem200816101821018910.1016/j.bmc.2008.10.06119013823 </plain></SENT>
</text></ref><ref id="R35"><text><SENT sid="206" pm="."><plain>35MoritaHOshimiSHirasawaYKoyamaKHondaTEkasariWCassiarins A and B, novel antiplasmodial alkaloids from Cassia siameaOrg Lett200793691369310.1021/ol701623n17685627 </plain></SENT>
</text></ref><ref id="R36"><text><SENT sid="207" pm="."><plain>36JullianVBourdyGGeorgesSMaurelSSauvianMValidation of use of a traditional antimalarial remedy from French Guiana, Zanthoxylum rhoifolium LamJ Ethnopharmacol200610634835210.1016/j.jep.2006.01.01116504432 </plain></SENT>
</text></ref><ref id="R37"><text><SENT sid="208" pm="."><plain>37 Mazier D, Carraz M, Franetich JF, Jossang A, Joyean R, Rasoanaivo P, et al. </plain></SENT>
<SENT sid="209" pm="."><plain>Alkaloid compounds and their use as antimalarial drugs. </plain></SENT>
<SENT sid="210" pm="."><plain>International Patent Application No. </plain></SENT>
<SENT sid="211" pm="."><plain>PCT/EP2005/005239, 21 April 2005.  </plain></SENT>
</text></ref><ref id="R38"><text><SENT sid="212" pm="."><plain>38 Mozaffarian V. </plain></SENT>
<SENT sid="213" pm="."><plain>A Dictionary of Iranian Plant Name [In Persian]. </plain></SENT>
<SENT sid="214" pm="."><plain>6th ed.Tehran: Farhang Moaser Press; 1996. p. </plain></SENT>
<SENT sid="215" pm="."><plain>207-208.  </plain></SENT>
</text></ref><ref id="R39"><text><SENT sid="216" pm="."><plain>39ModaressiMDelazarANazemiyehHFathi-AzadFSmithERahmanMMAntibacterial iridoid glucosides from Eremostachys laciniataPhytother Res2009239910310.1002/ptr.256818693303 </plain></SENT>
</text></ref><ref id="R40"><text><SENT sid="217" pm="."><plain>40DelazarAShoebMKumarasamyYByresMNaharLModarresiMTwo bioactive ferulic acid derivatives from Eremostachys glabraDaru200412: 24951 </plain></SENT>
</text></ref><ref id="R41"><text><SENT sid="218" pm="."><plain>41GharabaghiPMZamanyPDelazarAGhojazadehMGoldustMEfficacy of Eremostachys laciniata herbal extract on mitigation of pain after hysterectomy surgeryPak J Biol Sci20131689189410.3923/pjbs.2013.891.89424498845 </plain></SENT>
</text></ref><ref id="R42"><text><SENT sid="219" pm="."><plain>42KhanSNisarMSimjeeSURehmanWKhanRJanIEvaluation of micronutrients level and antinociceptive property of Eremostachys laciniata (L) BungeAfr J Biotechnol20109: 5775777 </plain></SENT>
</text></ref><ref id="R43"><text><SENT sid="220" pm="."><plain>43NisarMKhanSDarARehmanWKhanRJanIAntidepressant screening and flavonoids isolation from Eremostachys laciniata (L) BungeAfr J Biotechnol201110 :91696169910.5897/AJB10.1254 </plain></SENT>
</text></ref><ref id="R44"><text><SENT sid="221" pm="."><plain>44DelazarASarkerSDNaharLBarzegar JalaliSModaresiMHamedeyazdanSRhizomes of Eremostachys laciniata: isolation and structure elucidation of chemical constituents and a clinical trial on inflammatory diseasesAdvan Pharm Bull2013338539310.5681/apb.2013.06224312865 </plain></SENT>
</text></ref><ref id="R45"><text><SENT sid="222" pm="."><plain>45AfsharFHDelazarAJannehONazemiyehHPasdaranANaharLEvaluation of antimalarial, free-radicalscavenging and insecticidal activities of Artemisia scoparia and A spicigera, AsteraceaeBraz J Pharm20112198699010.1590/S0102-695X2011005000144 </plain></SENT>
</text></ref><ref id="R46"><text><SENT sid="223" pm="."><plain>46MalaguarneraLMusumeciSThe immune response to Plasmodium falciparum malariaLancet Infec Dis2002247247810.1016/S1473-3099(02)00344-412150846 </plain></SENT>
</text></ref><ref id="R47"><text><SENT sid="224" pm="."><plain>47GoldbergDESlaterAFGCeramiAHendersonGBHemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelleProc Nation Acad Sci USA19908729313510.1073/pnas.87.8.2931 </plain></SENT>
</text></ref><ref id="R48"><text><SENT sid="225" pm="."><plain>48TekwaniBLWalkerLATargeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro b-hematin formation assayCom Chem High T Scr20058637910.2174/1386207053328101 </plain></SENT>
</text></ref><ref id="R49"><text><SENT sid="226" pm="."><plain>49BandyopadhyayUDeySAntimalarial drugs and molecules inhibiting hemozoin formation Apicomplexan ParasitesMol Appr Targ Drug Develop201120523410.1002/9783527633883.ch11 </plain></SENT>
</text></ref><ref id="R50"><text><SENT sid="227" pm="."><plain>50SonnetPMullieCIn vitro antimalarial activity of ICL670: A further proof of the correlation between inhibition of b-hematin formation and of peroxidative degradation of heminExp Parasitol2011128263110.1016/j.exppara.2011.01.01821295029 </plain></SENT>
</text></ref><ref id="R51"><text><SENT sid="228" pm="."><plain>51WenzelNIChavainNWangYFriebolinWMaesLPradinesBAntimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNAJ Med Chem20102232142610.1021/jm901838320329733 </plain></SENT>
</text></ref><ref id="R52"><text><SENT sid="229" pm="."><plain>52VargasSNdjoko IosetKHayAEIosetJRWittlinSHostettmannKScreening medicinal plants for the detection of novel antimalarial products applying the inhibition of β-hematin formationJ Pharm Biomed Anal20115688088610.1016/j.jpba.2011.06.02621872416 </plain></SENT>
</text></ref><ref id="R53"><text><SENT sid="230" pm="."><plain>53NcokaziKKEganTJA colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compoundsAnal Biochem2005153061910.1016/j.ab.2004.11.02215745752 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
